Application 216349
- Type
- ANDA
- Sponsor
- GRAVITI PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | CAPSULE, DELAYED RELEASE;ORAL | EQ 20MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 16571-880 | ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | Rising Pharma Holdings, Inc. | ANDA | Current |
| 69844-050 | esomeprazole magnesium | esomeprazole magnesium | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 69844-050 | esomeprazole magnesium | esomeprazole magnesium | Graviti Pharmaceuticals Private Limited | ANDA | Current |